Detalhe da pesquisa
1.
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.
Circulation
; 148(2): 144-158, 2023 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37125593
2.
Biocompatibility Considerations for Orally Inhaled and Nasal Drug Products and Other Drug--Device Combination Products.
PDA J Pharm Sci Technol
; 78(1): 125-139, 2024 Feb 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37973193